Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429071

Director bought 9,411 shares at an average $26.45 ($248,891)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MARAGANORE JOHN Director 2026-10-22 Purchase +8,239 $26.38 $217,344 8,239 I: show line 1 in the form
MARAGANORE JOHN Director 2026-10-22 Purchase +1,172 $26.92 $31,547 9,411 I: show line 2 in the form
Open-market purchases · 9,411 sh · avg $26.45 · $248,891
Loading xslF345X06/ownership.xml…